Leading Global Pharma Joins Danish Enterprises, Startups and Public Health Systems Using AI Factories to Improve Drug Discovery and Healthcare Novo Nordisk / DCAI NVIDIA is collaborating with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. PARIS, June 11, 2025 (GLOBE NEWSWIRE) -- NVIDIA GTC Paris at VivaTech — NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. The work supports Novo Nordisk’s ag ...

REDWOOD CITY, Calif., April 30, 2025 /PRNewswire/ -- Quarterly revenues of $2.2 billion, an increase of 5% over the same quarter last year as-reported, or 8% on a normalized and constant currency basis, excluding the impact of power pass-through Sustained demand and improved sales execution resulted in gross and net bookings above our expectations for the quarter Strategy resonating with the marketplace, providing continued confidence in 2025 outlookEquinix, Inc. (Nasdaq: EQIX), the world's digital infrastr ...

Core Insights - ePlus inc. has achieved the status of NVIDIA DGX SuperPOD Specialization Partner, enhancing its capabilities in delivering AI infrastructure solutions [1][2] - The company emphasizes its commitment to helping organizations adopt AI technology effectively, addressing the challenges of infrastructure and scalability [2] - NVIDIA DGX SuperPOD is highlighted as a high-performance AI infrastructure platform that integrates various NVIDIA technologies to optimize enterprise AI workloads [2][3] Company Overview - ePlus is recognized as a customer-first, services-led industry leader, providing a wide range of technology solutions including AI, security, cloud, and data center services [5][7] - The company has over 2,200 employees and a strong presence in multiple regions including the United States, United Kingdom, Europe, and Asia-Pacific [5][7] AI Solutions and Services - ePlus offers a comprehensive AI Ignite Portfolio that includes workshops, assessments, and advanced services to support organizations in their AI journey [3][6] - The ePlus Secure GenAI Accelerator is a new offering designed to help organizations explore and test Generative AI use cases securely and efficiently [3] Technical Expertise - The company specializes in the design and deployment of NVIDIA DGX SuperPOD configurations, ensuring optimal performance for AI training and research [6] - ePlus provides advanced support services that include monitoring and ongoing optimization of AI workloads, enhancing operational efficiency [6]

下一个黄金赛道。 作者 I 岳笑笑 报道 I 投资界PEdaily 黄仁勋又出手了。 本周，黄仁勋现身越南，期间宣布一则消息：英伟达已收购越南医疗保健初创公司 Vi nBr a i n。 这一笔交易看似意外，却又有迹可循。今年以来，黄仁勋在多个公开场合强烈表示了对AI医疗的狂热。这一次，他买下越南明星AI医 疗大模型公司——Vi nBr a i n，成为押注AI医疗的又一注脚。如今打开Vi nBr a i n的官网，"Vi nBr a i n is now a pa rt of NVIDIA"的通知 已经出现在主页。 买了一个AI医疗团队 被黄仁勋看中，Vi nBr a i n有何来头？ 资料显示，Vi nBr a i n的创始人是St e ve n Tr u on g。他曾在人工智能和软件行业工作了26年，就职于霍尼韦尔、I n t e lliCommuniti e s等顶 级技术公司，还是微软人工智能产品平台的关键发起人。 图源官网 2019年，St e ve n Tr uong回到越南，在照顾中风的年迈母亲时，他感受到到医院过度拥挤给患者及其家人带来的不便。结合自身经 历，他产生了将AI与医疗结合创业的 ...